Clinical Trials Logo

AHUS clinical trials

View clinical trials related to AHUS.

Filter by:
  • None
  • Page 1

NCT ID: NCT05405777 Not yet recruiting - aHUS Clinical Trials

A Retrospective Study to Evaluate the Clinical Outcome According to Treatment in aHUS Patients in South Korea

Start date: June 14, 2022
Phase:
Study type: Observational

Primary objective - To determine the clinical prognosis by identifying the disease course and severity by treatment with or without eculizumab in patients with aHUS in Korea. Secondary objectives - To determine the clinical prognosis of the disease in all patients with aHUS in Korea. - To determine the clinical prognosis of the disease in patients diagnosed with aHUS prior to the initiation of eculizumab reimbursement system in Korea. - To determine the treatment responses by treatment options in patients with aHUS in Korea. - To identify risk factors that affect mortality in all patients with aHUS in Korea. - To investigate the recurrence and clinical prognosis in patients with aHUS in Korea when eculizumab is discontinued

NCT ID: NCT04749810 Completed - Clinical trials for Atypical Hemolytic Uremic Syndrome

Observational Study of Elizaria® in aHUS Patients

Start date: December 19, 2019
Phase:
Study type: Observational

It is a multicenter observational non-comparative study of the efficacy and safety of long-term pathogenetic Elizaria® therapy in patients with atypical Hemolytic Uremic Syndrome

NCT ID: NCT04725812 Terminated - Pregnancy Related Clinical Trials

Complement Regulation to Undo Systemic Harm in Preeclampsia

CRUSH
Start date: September 13, 2021
Phase: Phase 2
Study type: Interventional

This is a Phase II, single arm, open-label study to determine if treatment with eculizumab prolongs pregnancy compared to historical controls in women with preeclampsia between 23-30 weeks gestation.